Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?

Podobné jednotky

• Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
  Autor: Mukhtyar, C, a další
  Vydáno: (2006)
• Cardiovascular outcomes in antineutrophil cytoplasm antibody associated vasculitis (AAV)
  Autor: Mukhtyar, C, a další
  Vydáno: (2008)
• Is rituximab “The Wonder Drug” for antineutrophil cytoplasmic antibodies-associated vasculitis?
  Autor: Saket Jha, a další
  Vydáno: (2019-01-01)
• Severe Infections following Rituximab Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
  Autor: Zhi-Ying Li, a další
  Vydáno: (2020-08-01)
• A Case of Postcoronavirus Disease 2019 Antineutrophil Cytoplasmic Antibody-associated Vasculitis Successfully Treated with Rituximab
  Autor: Mahmoud M. Mohamed, a další
  Vydáno: (2023-07-01)